ASAH1 — N-Acylsphingosine Amidohydrolase 1

ASAH1 — N-Acylsphingosine Amidohydrolase 1

Overview

Asah1 — N Acylsphingosine Amidohydrolase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

ASAH1 — N-Acylsphingosine Amidohydrolase 1

Overview

Asah1 — N Acylsphingosine Amidohydrolase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<div class="infobox infobox-gene"> [@decreased1918]
<table> [@ceramide2019]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">ASAH1 — N-Acylsphingosine Amidohydrolase 1</th></tr> [@acid2020]
<tr><td><strong>Gene Symbol</strong></td><td>ASAH1</td></tr> [@targeting]
<tr><td><strong>Full Name</strong></td><td>N-Acylsphingosine Amidohydrolase 1 (Acid Ceramidase)</td></tr>
<tr><td><strong>Chromosome</strong></td><td>8p22</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[4153](https://www.ncbi.nlm.nih.gov/gene/4153)</td></tr>
<tr><td><strong>OMIM</strong></td><td>613468</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000104522</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q13510](https://www.uniprot.org/uniprot/Q13510)</td></tr>
<tr><td><strong>Protein Name</strong></td><td>Acid Ceramidase</td></tr>
<tr><td><strong>Protein Length</strong></td><td>395 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~44 kDa (precursor), ~13+20 kDa (processed)</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>Ubiquitous, high in brain, liver, kidney</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), [Farber Disease](/diseases/farber-disease)</td></tr>
</table>
</div>

Introduction

ASAH1 (N-Acylsphingosine Amidohydrolase 1), also known as acid ceramidase (ACDase), is a lysosomal enzyme that catalyzes the hydrolysis of ceramides into sphingosine and free fatty acids. This reaction is a critical step in sphingolipid metabolism and the ceramide signaling pathway. ASAH1 is essential for maintaining lipid homeostasis, and mutations in ASAH1 cause the lysosomal storage disorder Farber disease. Recent research has implicated ASAH1 deficiency in the pathogenesis of neurodegenerative diseases including [Parkinson's disease](/diseases/parkinsons-disease-disease) (PD), [Alzheimer's disease](/diseases/alzheimers-disease) (AD), and amyotrophic lateral sclerosis (ALS), highlighting the importance of ceramide metabolism in neuronal survival.

Gene Structure and Expression

Genomic Location

The ASAH1 gene is located on chromosome 8p22 and consists of approximately 16 exons spanning about 28 kb of genomic DNA. The gene encodes a protein of 395 amino acids that is synthesized as a precursor and processed into a heterodimer.

Brain Expression Pattern

ASAH1 is ubiquitously expressed throughout the body, with high expression in the brain, liver, and kidney. In the central nervous system, ASAH1 is expressed in:

• [Neurons](/entities/neurons) (all regions)
• [Astrocytes](/entities/astrocytes)
• [Microglia](/cell-types/microglia-neuroinflammation)
• [Oligodendrocytes](/cell-types/oligodendrocytes) Vascular cells

• Cerebral [cortex](/brain-regions/cortex)
• [Hippocampus](/brain-regions/hippocampus) (CA1-CA3 and dentate gyrus)
• Cerebellum (Purkinje cells)
• Substantia nigra (dopaminergic neurons)
• Basal ganglia [1](https://human.brain-map.org/)

Protein Structure and Function

Enzyme Classification

ASAH1 belongs to the family of ceramidases, which hydrolyze the N-acyl linkage of ceramides. It is an acid-active enzyme (optimal pH ~4.5-5.0) localized primarily in lysosomes.

Structural Features

The ASAH1 protein has several important features:

Biological Functions

Ceramide Hydrolysis

ASAH1 catalyzes the hydrolytic cleavage of ceramides:

Ceramide + H₂O → Sphingosine + Fatty Acid

This reaction is part of the sphingolipid catabolic pathway and produces:

• Sphingosine: A bioactive lipid involved in cell signaling
• Free fatty acids: Used for energy or other metabolic processes

Sphingolipid Metabolism

ASAH1 plays a central role in sphingolipid metabolism:

Cell Signaling

ASAH1-derived sphingosine and sphingosine-1-phosphate (S1P) serve as important signaling molecules:

• Cell survival: S1P promotes cell survival
• Inflammation: Ceramide and sphingosine are pro-inflammatory
• [Autophagy](/entities/autophagy): Ceramide metabolism is linked to autophagy

Disease Associations

Parkinson's Disease (PD)

ASAH1 has emerged as an important gene in PD pathogenesis. Multiple studies have identified:

• Reduced ASAH1 expression in PD substantia nigra
• ASAH1 variants associated with increased PD risk
• Impaired ceramide metabolism in PD brain tissue

Key Studies

| Study | Year | Key Finding |
|-------|------|-------------|
| Bandopadhyay et al. | 2018 | Decreased ASAH1 in PD substantia nigra |
| Yang et al. | 2020 | ASAH1 variants increase PD risk |
| Liu et al. | 2022 | ASAH1 deficiency promotes α-synuclein aggregation |

Amyotrophic Lateral Sclerosis (ALS)

ASAH1 is implicated in ALS through:

Alzheimer's Disease (AD)

In AD brain:

• Altered ceramide metabolism
• Increased ceramide levels
• ASAH1 may affect amyloid processing

Farber Disease

Biallelic loss-of-function mutations in ASAH1 cause Farber disease:

• Lysosomal ceramidase deficiency
• Ceramide accumulation
• Neurological symptoms, arthritis, subcutaneous nodules

Molecular Mechanisms in Neurodegeneration

Ceramide Accumulation

ASAH1 deficiency leads to ceramide accumulation, which:

Mitochondrial Dysfunction

Ceramides impair mitochondrial function through:

• Direct inhibition of mitochondrial complexes
• Induction of mitochondrial permeability transition
• Promotion of mitophagy

Neuroinflammation

ASAH1 deficiency contributes to neuroinflammation:

• Ceramide activates microglia
• Pro-inflammatory cytokine release
• [Blood-brain barrier](/entities/blood-brain-barrier) disruption

Therapeutic Implications

Enzyme Replacement

Recombinant human acid ceramidase (rAC) is being developed for therapy:

• Approved for Farber disease (in development)
• Potential for neurodegenerative diseases

Small Molecule Modulators

• Ceramidase inhibitors: Reduce ceramide catabolism to increase levels
• Ceramidase activators: Enhance enzyme activity to reduce ceramide accumulation

Gene Therapy

AAV-delivered- [Parkinson's disease](/diseases/parkinsons-disease)d for:

• [Parkinson's disease](/diseases/parkinsons-disease) Amyotrophic lateral sclerosis
• [ASAH1 Protein](/proteins/asah1-protein) — Detailed protein information
• [Parkinson's Disease](/diseases/parkinsons-disease) — PD overview
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — ALS overview
• [Alzheimer's Disease](/diseases/alzheimers-disease) — AD overview
• [Ceramide Signaling](/mechanisms/ceramide-signaling) — Ceramide pathways
• [Sphingolipid Metabolism](/mechanisms/sphingolipid-metabolism) — Lipid metabolism
• [Genes](/genes) — All gene pages
• [Proteins](/proteins) — All protein pages
• [--](/proteins/n--cadherin-protein)

External Links

• [NCBI Gene — ASAH1](https://www.ncbi.nlm.nih.gov/gene/4153)
• [UniProt — ASAH1](https://www.uniprot.org/uniprot/Q13510)
• [Ensembl — ASAH1](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000104522)
• [Allen Human Brain Atlas](https://human.brain-map.org/)
• [OMIM — ASAH1](https://www.omim.org/entry/613468)

Overview

Asah1 — N Acylsphingosine Amidohydrolase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Asah1 — N Acylsphingosine Amidohydrolase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ASAH1 — N-Acylsphingosine Amidohydrolase 1 discovered through SciDEX knowledge graph analysis: